Ajay Aggarwal is a Consultant Clinical Oncologist at Guy’s & St Thomas’ NHS Foundation Trust, London, and a Professor of Cancer Services and Systems Research at the London School of Hygiene and Tropical Medicine in the Faculty of Public Health and Policy. His main research areas are cancer policy, performance assessment of cancer care and Global Health. He was appointed Clinical Director of the ten National Cancer Audits in England and Wales in 2023, which is one of the largest national cancer quality assurance and improvement programs in the world. He is the current Editor-in-Chief of the Journal of Cancer Policy. The results of his research have contributed significantly to national and international policy discussions around the affordability of cancer care and the value of new technologies in cancer medicine. As Co-Chair of the Health Economics in Radiation Oncology (HERO) group within the European Society for Radiation Oncology (ESTRO), he is one of the leads of the value-based healthcare initiative. He is the Chief Investigator of the NIH funded ARCHERY study, the first prospective international multicentre trial across India, Jordan, Malaysia and South Africa evaluating the role of AI in radiotherapy.
Updated: September 2024